Project Grant R21HD120973
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services National Institutes of Health, awarded $456,500 to The University of Texas Southwestern Medical Center on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds molecular characterization of human pregnancy-induced cervical epithelium through two research aims. First, the recipient will apply single-cell and spatial...
- The National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services National Institutes of Health, awarded $157,000 to Rutgers The State University of New Jersey, School of Nursing on September 1, 2026 under the Child Health and Human Development Extramural Research program (CFDA 93.865). The award funds a project examining severe maternal morbidity risk in New Jersey through analysis of linked birth records and hospital discharge data. The...
- The National Institute of Child Health and Human Development awarded Emory University $426,948 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to develop and validate artificial intelligence models that integrate electronic health record data to identify clinically meaningful subtypes of hypertensive disorders of pregnancy and predict disease onset before clinical diagnosis. The project will model longitudinal physiological changes and...
- This $382,226 Project Grant from the Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development supports the development of a platform for uncovering new drug safety information through analysis of linked electronic health records. Vanderbilt University Medical Center will analyze 48,434 linked maternal and neonatal EHRs to apply a medication-wide association study and discover associations between maternal drug exposures and...
- The National Institute of Child Health and Human Development awarded Vanderbilt University Medical Center $785,385 on September 2, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to evaluate the safety and efficacy of glucagon-like peptide-1 receptor agonists (semaglutide, liraglutide, tirzepatide) for pre-pregnancy weight management and pregnancy outcomes. The research leverages the National Patient Centered Clinical Research Network to conduct a...
- The National Heart, Lung, and Blood Institute awarded Vanderbilt University Medical Center $154,142 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to study preeclampsia recurrence risk and identify mitigation strategies. The award funds a five-year research and career development project running through June 30, 2031, centered at Nashville, Tennessee. The research establishes the relationship between preeclampsia subtypes and recurrence risk in a...
- The National Institute of Child Health and Human Development awarded Massachusetts General Hospital $499,918 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the genetic etiologies of stillbirth as an extreme manifestation within the developmental disorders continuum. The recipient will aggregate genomic and phenotypic data from an initial sequencing cohort of more than 1,000 stillbirth cases and their family members,...
- The National Institute of Child Health and Human Development awarded The Children's Hospital of Philadelphia $795,088 on June 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a cluster randomized controlled trial evaluating doula support and healthcare navigation for mothers of preterm infants in neonatal intensive care units. The study, titled Postpartum Care in the NICU (PELICAN), addresses maternal postpartum mortality risk among...
- The National Institute of Child Health and Human Development awarded The General Hospital Corporation (Massachusetts General Hospital) $443,954 on June 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct a four-year mixed-methods assessment of obstetric readiness in low-resource emergency departments. The research addresses the clinical gap created by closures of labor and delivery units that leave 2.3 million women of childbearing age in...
- The National Institute of Child Health and Human Development awarded $3.328 million to the University of South Carolina on September 15, 2025, under CFDA 93.865 (Child Health and Human Development Extramural Research) to conduct research examining the impact of 12-month postpartum Medicaid insurance extensions on maternal and newborn health outcomes through August 31, 2027. The research uses a natural experiment comparing maternal health outcomes and healthcare utilization for women enrolled...
The National Institute of Child Health and Human Development awarded Vanderbilt University Medical Center $481,250 on September 1, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.865, R21HD120973) to investigate associations between adverse pregnancy outcomes, severe maternal morbidity, maternal mortality, and cardiovascular events across women's complete reproductive histories. The recipient will assemble retrospective cohort studies combining Tennessee's birth and death certificate registries with hospitalization records to reconstruct complete reproductive histories and examine how cumulative adverse pregnancy outcomes—including hypertensive disorders of pregnancy, gestational diabetes, spontaneous preterm delivery, stillbirth, perinatal death, and small-for-gestational-age infants—correlate with severe maternal morbidity in current or future pregnancies and long-term cardiovascular risk. The project addresses a gap in prior research, which has focused predominantly on single adverse outcomes rather than their cumulative influence or specific combinations. Place of performance is Forest Hills, Tennessee. The award period runs September 1, 2026, through August 31, 2028. The assistance type is a Project Grant, categorized as R21 support within NICHD's extramural research portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $481.3k | 8/28/26 |